SUPN

NASDAQ · Pharmaceuticals

Supernus Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$43.39

-0.36 (-0.82%)

As of Sep 23, 8:40 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 2 18%

Sell 0 0%

Price Target

Analyst Price Target +109.3% upside

Low Target $64.19

Average Target $90.83

High Target $118.96

Current Price $43.39

Current
$43.39

Target
$90.83

$64.19 $90.83 avg $118.96

Scenario Analysis

Bear Case

$64.19

47.9%

Low target

Base Case

$90.83

+109.3%

Avg target

Bull Case

$118.96

+174.2%

High target

Risk/Reward

3.6x

Highly favorable

Price in Context

52-Week High

$59.68

-27.3% from high

52-Week Low

$40.51

+7.1% from low

50-Day SMA

$49.76

-12.8% vs SMA

200-Day SMA

$43.00

+0.9% vs SMA

RSI (14)

59.9

Neutral

Target vs 52W High

$90.83

+52.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+15.6%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+7.6%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+20.3%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+185.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.1%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+193.1%